Qualigen Therapeutics Inc (QLGN) — Free Cash Flow Generation Index

Latest as of September 2023: 1.27x

Qualigen Therapeutics Inc (QLGN) has a Free Cash Flow Generation Index of 1.27x as of September 2023. Free cash flow of $1.18 Million represents 1% of operating cash flow ($929.74K). See QLGN current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.

FCF Generation Index

1.27x
Free Cash Flow / Operating CF

Free Cash Flow

$1.18 Million
USD

Operating Cash Flow

$929.74K
USD

Capital Expenditures

$246.42K
USD

Qualigen Therapeutics Inc Free Cash Flow Generation Index (2019–2019)

Historical FCF Generation Index trend for Qualigen Therapeutics Inc across 1 annual periods. Explore Qualigen Therapeutics Inc cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.

Annual Free Cash Flow Generation for Qualigen Therapeutics Inc (2019–2019)

Year-by-year Free Cash Flow Generation Index for Qualigen Therapeutics Inc. For the full company profile including market capitalisation, see market cap of Qualigen Therapeutics Inc.

Year FCG Index Free Cash Flow (USD) Operating CF Capital Expenditures YoY Change
2019 -2.39x $-137.15K $57.33K $194.48K
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).